Viveve Medical, Inc. provided preliminary revenue guidance for the fourth quarter ended December 31, 2015. For the quarter, total revenue from the sale of 21 Viveve Systems and 216 treatment tips is expected to be approximately $750,000 - nearly a 30% increase over total revenue for the quarterly period ended September 30, 2015.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -50.00% |
2023 | InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc. | CI |
2023 | Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 10 | |
+0.80% | 204B | |
+3.22% | 178B | |
+29.20% | 154B | |
+31.56% | 112B | |
+1.75% | 64.32B | |
+19.56% | 54.88B | |
-2.27% | 47.24B | |
-9.61% | 36.8B | |
-0.67% | 35.26B |
- Stock Market
- Equities
- VIVE Stock
- News Viveve Medical, Inc.
- Viveve Medical, Inc. Provides Preliminary Revenue Guidance for the Fourth Quarter Ended December 31, 2015